Slide 1: Investor Presentation - Boom of the Biotech - Nov 2023
For personal use only Investor Presentation — Boom of the Biotech - Nov 2023 ASX: AUA Approved for release by the Board of Audeara Limited.
Slide 2: Disclaimer | Important information
Disclaimer | Important information For personal use only November 2023 This presentation has been prepared by Audeara Limited ACN 604 368 443 (Company) for the sole purpose of providing the Recipient with general information only. This presentation does not purport to be complete, nor does it contai
Slide 3: Business overview
Business overview For personal use only Audeara AUA Technology Headphone and accessories sales: Audeara ▸ White label products for large ▸ Partnerships with domestic Proprietary Technology third parties and international audiology ▸ Highly scalable technology clinic chains Hardware | Firmware | Soft
Slide 4: Financial overview
Financial overview For personal use only $2.9m $0.77m $0.67m $1.96m Q1FY24 Operating In Cash or Equivalents FY23 Revenue Q1FY24 Cash Receipts Cash Outflow at 30 Sep 2023 well placed to advance 40% YOY 30% QoQ 41% YOY international expansion Audeara (FY23) AUA Technology 30% YOY 80% YOY 49% YOY $153k
Slide 5: Audeara: Hardware and software solutions for the hearing industry
For personal use only Audeara Hardware and software solutions for the hearing industry
Slide 6: The Audeara difference / Who is Audeara for?
The Audeara difference Who is Audeara for? For personal use only Audeara headphones use Audeara is for people of all hearing abilities. The primary end users of our products are a hearing check algorithm^ people who are seeking solutions in an audiology clinic setting who fit into these groups: to t
Slide 7: Clients | Audiology clinics
Clients | Audiology clinics For personal use only The PROBLEM for audiology clinics Audeara’s SOLUTION for audiology clinics 45% Additional revenue stream of self declared hearing impaired adopt As an Assistive Listening Device (ALD), Audeara provides clinics hearing aids* with an additional revenue
Slide 8: Clients | Audiology clinics: international opportunities
Clients | Audiology clinics For personal use only Australia Audeara’s Number of locations that currently stock international opportunities Audeara (including sub-brands) (including sub-brands) By 2030, nearly 645# ~9,241 locations# in 25 countries 1 1.9 2,119.1 million EUR Consolidated Revenue 1 400
Slide 9: International distribution
International distribution An established footprint and near term international expansion opportunities For personal use only ASIAPAC Australia ▸ Currently stocked in over 1400 clinics Currently stocked in ▸ Primary revenue stream FY23 8 countries China, Taiwan and Singapore ▸ Australia ▸ Hungary ▸
Slide 10: AUA Technology: Third party product development and technology licensing
AUA Technology For personal use only Third party product development and technology licensing Leverage Audeara Proprietary Technology for strategic opportunities in audiology and consumer electronics industry. Audeara product pipeline Utilise Audeara Proprietary Technology to develop products in Aud
Slide 11: Taiwan's largest hearing aid retailer Clinico Inc.
Taiwan’s largest hearing aid retailer Clinico Inc. For personal use only Cooperative agreement following strategic $2.8M investment at $0.10 cps (a 20% premium at time of trading) Product development Exclusive distribution Developing a series of healthy In Taiwan and China, Audeara hearing earbuds i
Slide 12: Global musical instrument brand
Global musical instrument brand For personal use only Product development nearing completion Engineering fee for Contract manufacturing services underway and licensing H2 FY24 ▸ Design High volume consumer ▸ Sourcing markets with global reach ▸ Product development Highly scalable products with well
Slide 13: A defined strategy to grow and diversify sales
A defined strategy to grow and diversify sales For personal use only $2,905,985 Australian Wholesale $153,845 ▸ Focus on increasing sales per clinic $111,458 $246,307 AUA Technology $2,394,375 ▸ Engineering Services $2,067,410 $61,969 International Wholesale $165,448 ▸ EU - global chains $1,839,993
Slide 14: Contact
For personal use only Contact CORPORATE & MEDIA ENQUIRIES INVESTOR ENQUIRIES Dr James Fielding Six Degrees Investor Relations Managing Director and Chief Executive Officer Henry Jordan +61 (0) 431 271 538 james.fielding@audeara.com henry.jordan@sdir.com.au
Slide 15: Board Members
Board Members For personal use only Dr. James Fielding David Trimboli Dr. Elaine Saunders Bill Peng CEO and Managing Director Non-Executive Chairman Non-Executive Director Executive Director Dr Fielding completed dual Mr Trimboli helped launch Dr Saunders is a Biomedical Mr Peng has extensive experi
Slide 16: Company snapshot
Company snapshot For personal use only Enterprise value (A$) Top shareholders Share price $0.031 Name Shares Percentage Market cap $4.45M at 14 November 2023 Fortune Pioneer 28,000,000 19.5% Cash As at 30 September 2023 $1.96M Directors/Founders 34,605,652 23.3% Debt As at 30 September 2023 $0 Other
Slide 17: Innovative product pipeline
Innovative product pipeline For personal use only Tailored listening software ▸ Audeara app (consumer mobile app) Headphones with tailored sound ▸ AudAssist (desktop app for clinics) A-01 Headphones A-02 Headphones A-03 Headphones Kids Research and development underway ▸ Musicians ▹ Hearing protecti